The New York Times publishes an article on The Federal Trade Commission’s investigation on Lumosity’s marketing claims. These advertising claims stated patients with cognitive trauma or impairment would benefit from the brain training Lumosity provides.
At this time, there is not enough evidence to support the idea that cognitive training works and to which specific population it would benefit.
The theory in question: Would cognitive training affect people’s ability to function in their daily activities positively? Would this training assist people with handling their finances or remember exactly which items to buy at the grocery store?
Research on this idea continues with hopes of discovering a new tool to deal with Alzheimer’s Disease and dementia.
New York Times News Article: